How agile and sustainable is your supply chain? What is your approach to data transparency? How can you improve the efficiency and cost of the supply chain?

30 August 2022
Supply Chain to Patient
Lesley Holt
Phorum Director

The pharmaceutical outbound supply chain faces these and many more tough questions every day. Whilst delivering new modalities, it must meet capacity constraints, increasing costs, and greater complexity more challenging than ever before.

Overcoming these challenges will need an innovative solution that pulls on business acumen and experience from across industry – and this is why BioPhorum has launched the Supply Chain to Patient Phorum.

The work will be guided by a team of outstanding technical experts from across the biopharmaceutical industry and will transform the performance of global pharmaceutical clinical and commercial outbound supply chains.

The ambition is to reduce the complexity and cost, accelerate deployment of member supply chain strategies, establish the supply chain of the future, align on regulatory understanding, and provide industry benchmarks.

The team will shape industry’s clinical and commercial outbound supply chain ambitions and stand together as the ‘one voice’ of industry to influence the development of standards and the regulatory environment.
The team has already been busy identifying collaboration opportunities across the supply chain from drug substance/fill finish/CMO facilities, through central warehousing and wholesalers/distributors, and on to the pharmacy/hospital and the patient. These include:

  • Cold chain management
  • CMO interfaces and managing data flows
  • Software systems integration.
  • Customs information and guidance
  • The acceleration of electronic labeling
  • Supply chain strategies for new business models and modalities, e.g., cell and gene therapies, direct to patient shipping
  • Supply chain sustainability

Some of its early deliverables include three podcasts:

  • The first talks about freight capacity and increased costs, the complexity of cell and gene therapy and direct-to-patient supply chains, and the benefits of collaboration when influencing regulations.
  • The second covers data management and transparency challenges for biopharmaceutical logistics. It also discusses what happens if the challenges are not addressed and what BioPhorum collaborations are tackling them.
  • The third discusses the needs and considerations of a sustainable outbound supply chain.

Do you want to hear more about the benefits of this exciting new Phorum? And see how you can share your experience and learn from your peers? Then please get in touch with Lesley Holt, Supply Chain to Patient Phorum Director, at

Arrow On Colourful Background
Do you want to influence the future of long-range planning?
Improving Supply Chain Quality Management Through A Common Language
Improving supply chain quality management through a common language
DNA Strand & Digital Earth
BioPhorum’s patient-centric framework for developing the inbound supply chain
Demand Planning Text
Supplier and raw material improvements using BioPhorum’s maturity assessment toolkit
BioPhorum introduces – Pandemic to endemic – a catalyst for supply chain transformation

Advanced Therapy Medicinal Products

Advanced Therapy Medicinal Products support the quest for better and faster development of cell, gene and RNA therapies​ through connecting therapy developers, contract manufacturing, and testing organizations to gain an understanding and respond to the challenges faced by the advanced therapeutics industry.

Development Group

Development Group accelerates and improves the development process of biopharmaceutical medicines for the benefit of the patient. Replacing isolation with collaboration by providing a “safe” space where subject matter experts can work on sharing solutions and best practice on emerging industry trends, implementation of new technologies and common issues whilst ensuring their intellectual property and confidentiality is protected.

Drug Substance

Drug Substance advances excellence in drug substance manufacturing and testing, acting as an industry voice to accelerate technology adoption, implement post-approval change more rapidly and increase confidence in maintaining compliance.

Fill Finish

Fill Finish accelerates development and acceptance of sustainable world-class filling and packaging operations for drug product which meets the future needs of patients. Through innovative solutions resulting from the sharing of expertise, we can overcome common performance challenges and deliver on quality and regulatory compliance.

Information Technology

Information Technology accelerates digital maturity across the ​global pharmaceutical manufacturing industry.


BioPhorum Quality provides a dedicated, safe space for quality professionals from biomanufacturers and contract organizations to coalesce and enhance effective collaboration to address shared industry challenges.


Regulatory CMC brings leaders together who have a common goal – to improve access to medicines through innovation in the Regulatory ecosystem. It provides a dedicated space for strategic leadership and a coordinated industry voice, to move from divergence to convergence.

Supply Chain to Patient

Supply Chain to Patient transforms the performance of global pharmaceutical clinical and commercial outbound supply chains through industry collaboration by creating transparent patient-centric, resilient and agile E2E supply chains, that consistently deliver high-quality medicines ensuring an uninterrupted supply to patients.

Supply Partner

Supply Partner is a trusted advisory group and collaboration that is the engine for driving change across the global industry for all things relevant to the inbound supply chain. Addressing the challenges of complexity, resilience, cost, sustainability, and innovation.


Sustainability enables the industry’s transition to a low carbon, circular future – supporting members to improve patient health while respecting the planet. We activate multi-disciplinary teams drawn from our network to deliver environmental sustainability improvements across the value chain.

Technology Strategy

Technology Strategy acts as one voice of the industry to define strategy, accelerate technology transformation and support technology translation and adoption. With a purpose of enabling the future state of flexible, resilient, sustainable end-to-end biomanufacturing.

An industry perspective on understanding AAV capsid content variants
Needle On Yellow Background
An intercompany perspective on practical experiences of predicting, optimizing and analyzing high concentration biologic therapeutic formulations
The Drug Substance 2.0 Strategic Value Framework
Coloured dots on teal, next to vial
BioPhorum’s holistic approach to container closure integrity
Magnifying glass over a tablet all coloured blue
Digital Plant Maturity Model 3.0
Inaugural BioPhorum Quality face to face – get involved
The next step in building regulatory as a capability to enable strategic innovation across the BioPhorum community
Delivering a Cell and Gene Therapy Outbound Supply Chain Pathway for the Industry
DNA and Earth on blue background
A vision for the biopharmaceutical industry’s inbound supply chain
A major milestone – a harmonized approach to product carbon footprint data
Technology Roadmap V 2.0
BioPhorum Technology Roadmapping roadmap vision 2.0


Documents including best practices, vision statements and peer reviewed papers to help you take value back to your business.


Discussing all aspects of the biopharmaceutical industry, from digitization and knowledge management to raw materials, supply chain, sustainability and more. Learn from the perspectives of those at the forefront of the industry.


BioPhorum Connect is our podcast series that keeps you up to date with the latest news and trends in the biopharmaceutical industry. From experienced professionals to thought leaders, these podcasts bring you the insights and perspectives of experts from around the world.


A variety of resources including design tools and user requirement specifications to help you improve and streamline your business processes.

Benchmarks and Surveys

Research conducted among the BioPhorum membership providing evidence to support change and identify best practice.

Browse all

Access a variety of free tools and papers and other resources designed to provide you with up-to-date information and insights to help you make informed decisions and maximize your success. Access our resources today and start making improving and streamlining your business processes.

Bioreactivity testing in single-use system biomanufacturing
Bioreactivity testing in single-use system biomanufacturing
Bioreactivity testing in single-use system biomanufacturing
Magnifying glass over a tablet all coloured blue
Digital Plant Maturity Model 3.0
Bioreactivity testing in single-use system biomanufacturing